Omron Healthcare and physIQ have collaborated to integrate Omron’s FDA-cleared device, HeartGuide, the first wearable blood pressure monitor into the pinpointIQ platform to monitor at-risk patients in an outpatient setting. The strategic collaboration aims to generate actionable clinical information for at-risk patients in an outpatient environment.
The Omron HeartGuide is said to be a first-of-its kind wearable blood pressure monitor made in the form of a wristwatch. It uses oscillometric technology to measure medically-accurate blood pressure readings and monitors activity and sleep. PhysIQ’s pinpointIQ solution is an enterprise-ready, device-agnostic platform designed to capture continuous multivariate physiological data from wearable sensors, apply FDA-cleared Artificial Intelligence-based analytics, and provide actionable clinical information to a patient’s care team.
The initial implementation of the combined solution will be with a major Chicago-area integrated health system and focus on supporting post-discharge patients who have been hospitalized for either heart failure or heart attack. Patients will wear HeartGuide, which will transmit data through the physIQ mobile app to the pinpointIQ cloud-based platform. Clinicians will access patient data and analytics through the pinpointIQ user interface such that they can proactively manage their at-risk patients. For more information, visit Omron Healthcare and physIQ.